Supramolecular devices to improve the treatment of brain diseases

Drug Discovery Today

Volumn 16, Issue 7-8, 2011, Pages 311-324

  Paolino, Donatella ^a   Cosco, Donato ^b   Molinaro, Roberto ^a,b   Celia, Christian ^b   Fresta, Massimo ^b  

^a Faculty of Medicine   (Italy)

^b Faculty of Pharmacy   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; 1,2 DIOLEOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; ALPHA CYCLODEXTRIN; BENZAMIDINE; BETA CYCLODEXTRIN; CALIXARENE; CHOLESTERYL HEXADECYL ETHER; CROWN ETHER; CRYPTAND; CYCLODEXTRIN; CYCLOPHANE; DAUNORUBICIN; DIGOXIN; DISTEAROYLPHOSPHATIDYLETHANOLAMINE; DRUG CARRIER; ETHOSOME; GADOTERIDOL; GANGLIOSIDE GM1; LIPOSOME; MANNITOL; NANOGEL; NANOPARTICLE; NIOSOME; PHOSPHATIDYLETHANOLAMINE; POLY(4 ACRYLOYLMORPHOLINE); POLY(N,N DIMETHYLACRYLAMIDE); POLYMER; POLYSORBATE 80; POVIDONE; SPHERAND; UNCLASSIFIED DRUG;

ACTIVE TRANSPORT; BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG TRANSPORT; EMULSION; ENDOCYTOSIS; HUMAN; MICELLE; NANODEVICE; NONHUMAN; OPSONIZATION; PHYSICAL CHEMISTRY; REVIEW;

BLOOD-BRAIN BARRIER; BRAIN DISEASES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES;

EID: 79953675986     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2011.02.006     Document Type: Review

References (116)

1. M.M. Patel Getting into the brain: approaches to enhance brain drug delivery CNS Drugs 23 2009 35 58
2. W.M. Pardridge Blood-brain barrier delivery Drug Discov. Today 12 2007 54 61 (Pubitemid 46014479)
3. P.L. Golden, and G.M. Pollack Blood-brain barrier efflux transport J. Pharm. Sci. 92 2003 1739 1753 (Pubitemid 37071809)
4. Celia, C. et al. Nanoparticulate devices for brain drug delivery. Med. Res. Rev. doi:10.1002/med.20201 ; in press
5. M. Ricci Delivering drugs to the central nervous system: a medicinal chemistry or a pharmaceutical technology issue? Curr. Med. Chem. 13 2006 1757 1775 (Pubitemid 43871754)
6. S.A. Pathan CNS drug delivery systems: novel approaches Recent Pat. Drug Deliv. Formul. 3 2009 71 89
7. A.J. Sawyer New methods for direct delivery of chemotherapy for treating brain tumors Yale J. Biol. Med. 79 2006 141 152
8. W.M. Pardridge Molecular Trojan horses for blood-brain barrier drug delivery Discov. Med. 6 2006 139 143
9. G. Miller Drug targeting. Breaking down barriers Science 297 2002 1116 1118 (Pubitemid 36193322)
10. J. Rautio, and P.J. Chikhale Drug delivery systems for brain tumor therapy Curr. Pharm. Des. 10 2004 1341 1353 (Pubitemid 38559751)
11. H. Chen Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery Eur. J. Pharm. Sci. 40 2010 94 102
12. Y. Qin In vitro and in vivo investigation of glucose-mediated brain-targeting liposomes J. Drug Target. 18 2010 536 549
13. C. Dufes Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain Int. J. Pharm. 285 2004 77 85 (Pubitemid 39361538)
14. M. Kaiser Pre-clinical pharmacokinetics evaluation of an anticonvulsant candidate benzaldehyde semicarbazone free and included in beta-cyclodextrin Eur. J. Pharm. 39 2010 355 362
15. N. Nonaka Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins J. Pharmacol. Exp. Ther. 325 2008 513 519 (Pubitemid 351574811)
16. S. Soni Delivery of hydrophobised 5-fluorouracil derivative to brain tissue through intravenous route using surface modified nanogels J. Drug Target. 14 2006 87 95
17. D.E. Discher, and F. Ahmed Polymersomes Annu. Rev. Biomed. Eng. 8 2006 323 341 (Pubitemid 44314820)
18. D. Paolino Polyaspartylhydrazide copolymer-based supramolecular vesicular aggregates as delivery devices for anticancer drugs Biomacromolecules 9 2008 1117 1130
19. M.L. Immordino Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential Int. J. Nanomed. 1 2006 297 315
20. D. Cosco Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil Biomed. Microdevices 11 2009 1115 1125
21. M. Licciardi Folate-targeted supramolecular vesicular aggregates based on polyaspartyl-hydrazide copolymers for the selective delivery of antitumoral drugs Biomaterials 31 2010 7340 7354
22. D. Paolino Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity J. Control. Release 144 2010 144 150
23. P.B. Storm Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy J. Neuro-Oncol. 56 2002 209 217 (Pubitemid 34476989)
24. M.S. Lesniak Local delivery of doxorubicin for the treatment of malignant brain tumors in rats Anticancer Res. 25 2005 3825 3831 (Pubitemid 41665151)
25. M. Blanchette, and D. Fortin Blood-brain barrier disruption in the treatment of brain tumors Methods Mol. Biol. 686 2011 447 463
26. E. Neuwelt Strategies to advance translational research into brain barriers The Lancet Neurol. 7 2008 84 96 (Pubitemid 350258701)
27. A. Tsuji Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems NeuroRx 2 2005 54 62 (Pubitemid 40128026)
28. U. Bickel Delivery of peptides and proteins through the blood-brain barrier Adv. Drug Deliv. Rev. 46 2001 247 279
29. A. Béduneau Brain targeting using novel lipid nanovectors J. Control. Release 126 2008 44 49 (Pubitemid 351175685)
30. J. Kreuter Nanoparticulate systems for brain delivery of drugs Adv. Drug Deliv. Rev. 47 2001 65 81 (Pubitemid 32209233)
31. B. Petria Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants J. Control. Release 117 2007 51 58
32. J.C. Olivier Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity Pharm. Res. 16 1999 1836 1842
33. J. Kreuter Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles Pharm. Res. 20 2003 409 416 (Pubitemid 36288370)
34. J. Kreuter Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain J. Control. Release 118 2007 54 58 (Pubitemid 46283106)
35. K. Ulbrich Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB) J. Control. Release 71 2009 251 256
36. A. Zensi Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones J. Control. Release 137 2009 78 86
37. W.M. Pardridge Blood-brain nutrient transport Fed. Proc. 45 1986 2047 2049
38. W.M. Pardridge Human blood-brain barrier insulin receptor J. Neurochem. 44 1985 1771 1778 (Pubitemid 15000282)
39. W.A. Jefferies Transferrin receptor on endothelium of brain capillaries Nature 312 1984 162 163 (Pubitemid 14000081)
40. E. Garcia-Garcia Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain? Int. J. Pharm. 298 2005 274 292 (Pubitemid 40910731)
41. M.T. Peracchia Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting J. Control. Release 60 1999 121 128 (Pubitemid 29255834)
42. E. Fattal, and C. Vauthier Nanoparticles as drug delivery systems J. Swarbrick, J.C. Boylan, Encyclopedia of Pharmaceutical Technology Vol. 10 2002 Marcel Dekker New York 1864 1882
43. T. Ishida Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes J. Control. Release 105 2008 305 317 (Pubitemid 40941995)
44. E.T. Dams Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes J. Pharmacol. Exp. Ther. 292 2000 1071 1079 (Pubitemid 30136603)
45. H. Koide T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes Int. J. Pharm. 392 2010 218 223
46. T. Ishida Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes J. Control. Release 105 2005 305 317 (Pubitemid 40941995)
47. T. Ishida, and H. Kiwada Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes Int. J. Pharm. 354 2008 56 62
48. T. Ishihara Evasion of the accelerated blood clearance phenomenon by coating of nanoparticles with various hydrophilic polymers Biomacromolecules 11 2010 2700 2706
49. H. Xu Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes Biomaterials 31 2010 4757 4763
50. N. Denora Recent advances in medicinal chemistry and pharmaceutical technology - strategies for drug delivery to the brain Curr. Top. Med. Chem. 9 2009 182 196
51. B. Mukherjee Sustained release of acyclovir from nano-liposomes and nano-niosomes: an in vitro study Int. J. Nanomed. 2 2007 213 225 (Pubitemid 47215022)
52. D. Paolino Innovative drug delivery systems for the administration of natural compounds Curr. Bioact. Comp. 3 2007 262 277
53. S.P. Vyas, and K. Khatri Liposome-based drug delivery to alveolar macrophages Expert Opin. Drug Deliv. 4 2007 95 99 (Pubitemid 46389908)
54. S.M. Moghimi Long-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 2001 283 318 (Pubitemid 32476118)
55. D. Paolino Drug delivery systems 2nd edn J.G. Webster, Encyclopedia of Medical Devices and Instrumentation Vol. 2 2006 John Wiley & Sons Hoboken 437 495
56. D. Paolino In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery Biomed. Microdevices 9 2007 421 433
57. M.G. Calvagno Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes Curr. Drug Deliv. 4 2007 89 101 (Pubitemid 46066418)
58. D. Paolino Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers J. Control. Release 106 2005 99 110 (Pubitemid 41140085)
59. A.D. Bangham Diffusion of univalent ions across the lamellae of swollen phospholipids J. Mol. Biol. 13 1965 238 252
60. V. Torchilin, V. Weissig, Liposomes: A Practical Approach 2003 Oxford University Press
61. L. Coderch Influence of cholesterol on liposome fluidity by EPR: relationship with percutaneous absorption J. Control. Release 68 2000 85 95 (Pubitemid 30407064)
62. J. Senior, and G. Gregoriadis Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components Life Sci. 30 1982 2123 2136 (Pubitemid 12066826)
63. G.L. Scherphof, and J.A. Kamps The role of hepatocytes in the clearance of liposomes from the blood circulation Prog. Lipid Res. 40 2001 149 166 (Pubitemid 32220186)
64. A. Schnyder Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects J. Drug Target. 13 2005 325 335 (Pubitemid 41283166)
65. M. Demeule Identification and design of peptides as a new drug delivery system for the brain J. Pharmacol. Exp. Ther. 324 2008 1064 1072 (Pubitemid 351397849)
66. M. Demeule Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2 J. Neurochem. 106 2008 1534 1544
67. J. Huwyler Brain drug delivery of small molecules using immunoliposomes Proc. Natl. Acad. Sci. U. S. A. 93 1996 14164 14169 (Pubitemid 26424263)
68. H. Zhao A comparative study of transfection efficiency between liposomes, immunoliposomes and brain-specific immunoliposomes J. Int. Med. Res. 38 2010 957 966
69. N. Shi, and W.M. Pardridge Noninvasive gene targeting to the brain Proc. Natl. Acad. Sci. U. S. A. 97 2000 7567 7572 (Pubitemid 30431504)
70. J.Y. Li Genetically engineered brain drug delivery vectors: cloning, expression and in vivo application of an anti-transferrin receptor single chain antibody-streptavidin fusion gene and protein Protein Eng. 12 1999 787 796 (Pubitemid 29472086)
71. Zhang Absence of toxicity of chronic weekly intravenous gene therapy with pegylated immunoliposomes Pharm. Res. 20 2003 1779 1785 (Pubitemid 37449451)
72. M.T. da Cruz Improving lipoplex-mediated gene transfer into C6 glioma cells and primary neurons Exp. Neurol. 187 2004 65 75 (Pubitemid 38470013)
73. R. Gabathuler Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases Neurobiol. Dis. 37 2010 48 57
74. S. Gosk Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion J. Cereb. Blood Flow Metab. 24 2004 1193 1204 (Pubitemid 39482480)
75. M. Fresta Liposomes as in-vivo carriers for citicoline: effects on rat cerebral post-ischaemic reperfusion J. Pharm. Pharmacol. 46 1994 974 981
76. M. Fresta Enhanced therapeutic effect of cytidine-5′-diphosphate choline when associated with GM1 containing small liposomes as demonstrated in a rat ischemia model Pharm. Res. 12 1995 1769 1774 (Pubitemid 26004700)
77. U. Ito Maturation of ischemic injuries observed in Mongolian gerbils: introductory remarks U. Ito, T. Kirino, T. Kuroiwa, I. Klatzo, Maturation Phenomenon in Cerebral Ischemia 1992 Springer-Verlag 1 13
78. M. Fresta, and G. Puglisi Survival rate improvement in a rat ischemia model by long circulating liposomes containing cytidine-5I-diphosphate choline Life Sci. 61 1997 1227 1235 (Pubitemid 27390554)
79. W.M. Saltzman Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems Pharm. Res. 16 1999 232 240 (Pubitemid 29135127)
80. R.H. Bobo Convection-enhanced delivery of macromolecules in the brain Proc. Natl. Acad. Sci. U. S. A. 91 1994 2076 2080
81. C. Mamot Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery J. Neurooncol. 68 2004 1 9 (Pubitemid 39137344)
82. J.A. MacKay Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating Brain Res. 1035 2005 139 153 (Pubitemid 40250186)
83. D.M. Lieberman Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion J. Neurosurg. 82 1995 1021 1029
84. R. Saito Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery J. Neurosci. Methods 154 2006 225 232 (Pubitemid 43949058)
85. I.F. Uchegbu, and P.S. Vyas Non-ionic surfactant based vesicles (niosomes) in drug delivery Int. J. Pharm. 172 1998 33 70 (Pubitemid 28430243)
86. C. Marianecci Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts J. Control. Release 147 2010 127 135
87. M. Manconi Niosomes as carriers for tretinoin I. Preparation and properties Int. J. Pharm. 234 2002 237 248 (Pubitemid 34142628)
88. H.E. Hofland Safety aspects of non-ionic surfactant vesicles: a toxicity study related to the physicochemical characteristics of non-ionic surfactants J. Pharm. Pharmacol. 44 1992 287 294
89. D. Dimitrijevic The effect of monomers and of micellar and vesicular forms of non-ionic surfactants (Solulan C24 and Solulan 16) on Caco-2 cell monolayers J. Pharm. Pharmacol. 49 1997 611 616 (Pubitemid 27281430)
90. M. Tabbakhian Enhancement of follicular delivery of finasteride by liposomes and niosomes. 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models Int. J. Pharm. 323 2006 1 10 (Pubitemid 44397357)
91. A. Vangala A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice J. Pharm. Pharmacol. 58 2006 787 799 (Pubitemid 43836165)
92. S.P. Vyas Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B Int. J. Pharm. 296 2005 80 86 (Pubitemid 40693375)
93. D. Aggarwal, and I.P. Kaur Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system Int. J. Pharm. 290 2005 155 159 (Pubitemid 40139055)
94. C. Choeiri Immunohistochemical localization and quantification of glucose transporters in the mouse brain Neuroscience 111 2002 19 34 (Pubitemid 34310448)
95. J.S. Kim Hyperbranched calixarenes: synthesis and applications as fluorescent probes Chem. Commun. (Camb.) 32 2009 4791 4802
96. Y. Murakami, and O. Hayashida Supramolecular effects and molecular discrimination by macrocyclic hosts embedded in synthetic bilayer membranes Proc. Nat. Acad. Sci. U. S. A. 90 1993 1140 1145 (Pubitemid 23058129)
97. V. Monnaert Behavior of alpha-, beta-, and gamma-cyclodextrins and their derivatives on an in vitro model of blood-brain barrier J. Pharmacol. Exp. Ther. 310 2004 745 751 (Pubitemid 38988921)
98. F. Hirayama, and K. Uekama Cyclodextrin-based controlled drug release system Adv. Drug Deliv. Rev. 36 1999 125 141 (Pubitemid 29074480)
99. A.L. Laza-Knoerr Cyclodextrins for drug targeting J. Drug Target. 18 2010 645 656
100. V.J. Stella Mechanisms of drug release from cyclodextrin complexes Adv. Drug Deliv. Rev. 36 1999 3 16 (Pubitemid 29074473)
101. J. Szetjli Introduction and general overview of cyclodextrin chemistry Chem. Rev. 98 1998 1743 1754
102. F. Camargo Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease Life Sci. 70 2001 131 142 (Pubitemid 33153117)
103. S. Tilloy Methylated beta-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood-brain barrier Bioorg. Med. Chem. Lett. 16 2006 2154 2157 (Pubitemid 43351069)
104. M.P. Dehouck Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models J. Neurochem. 58 1992 1790 1797
105. T. Loftsson, and D. Duchêne Cyclodextrins and their pharmaceutical applications Int. J. Pharm. 329 2007 1 11 (Pubitemid 44937538)
106. G. Puglisi Interaction of natural and modified β-cyclodextrins with a biological membrane model of dipalmitoylphosphatidylcholine J. Colloid Interface Sci. 180 1996 542 547 (Pubitemid 26233934)
107. Y. Ohtani Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes Eur. J. Biochem. 186 1989 17 22 (Pubitemid 20015121)
108. S.V. Vinogradov Nanogels for oligonucleotide delivery to the brain Bioconjug. Chem. 15 2004 50 60 (Pubitemid 38165980)
109. S.V. Vinogradov Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells Adv. Drug Deliv. Rev. 54 2002 135 147 (Pubitemid 34075317)
110. S.V. Vinogradov Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells Bioconjug. Chem. 10 1999 851 860
111. V.Y. Alakhov, and A.V. Kabanov Block copolymeric biotransport carriers as versatile vehicles for drug delivery Expert Opin. Investig. Drugs 7 1998 1453 1473 (Pubitemid 28409557)
112. A. Gessner The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles Int. J. Pharm. 214 2001 87 91 (Pubitemid 32244084)
113. T.M. Göppert, and R.H. Müller Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting Int. J. Pharm. 302 2005 172 186 (Pubitemid 41242762)
114. W.M. Pardridge Biopharmaceutical drug targeting to the brain J. Drug Target. 18 2010 157 167
115. B. Vastag Biotechnology: crossing the barrier Nature 466 2010 916 918
116. M.T. Krauze Real-time imaging and quantification of brain delivery of liposomes Pharm. Res. 23 2006 2493 2504 (Pubitemid 44691597)